Pharmacy Reimbursement Pricing System for Generic Medication Selection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current prescription payment systems fail to effectively manage medication costs, as they do not adequately incentivize the use of lower-priced generic medications over brand name medications, leading to increased healthcare expenses and inefficient pharmacy operations.
Innovation Solution
A system that calculates a representative retail price for groups of medically similar medications, using average wholesale prices and maximum allowable costs, including discounts and dispensing fees, to encourage pharmacies to dispense lower-priced options by offering a fixed fee payment structure, while excluding new or high-priced medications from this calculation and using fee-for-service payments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of energy
If traditional reimbursement methodologies are used, then pharmacies receive payment based on individual medication pricing, but medication costs increase and generic medication selection is not adequately incentivized
Solution Approach 1:
The patent changes the reimbursement parameter from individual medication pricing to a fixed fee structure based on therapeutic equivalence groups. This allows pharmacies to receive consistent payment regardless of whether they dispense brand-name or generic medications, thereby incentivizing generic selection while maintaining operational simplicity through standardized fee schedules.
Solution Approach 2:
The patent segments medications into therapeutic equivalence groups where medications within each group are treated uniformly for reimbursement purposes. This segmentation allows the system to promote generic medications within each group while maintaining clear, manageable fee structures that simplify pharmacy operations.
2Productivity
If fixed fee payment structure is implemented for medication groups, then generic medication use is incentivized and costs are controlled, but new or high-priced medications must be excluded from calculation
Solution Approach 1:
The patent implements a dynamic pricing system where the fixed fee structure applies to established medication groups, while new or high-priced medications are initially excluded from calculations. This allows the system to adapt and evolve as new medications are introduced, maintaining flexibility while progressively expanding generic medication incentives as data becomes available.
Solution Approach 2:
The patent establishes fixed fee structures for medication groups in advance based on available data, creating predictable reimbursement rates that incentivize generic dispensing. New medications are initially excluded but can be incorporated into groups as more pricing and utilization data becomes available, allowing the system to prepare and adapt systematically.
3Measurement precision
If representative retail price calculations include all medications, then comprehensive cost control is achieved, but new or high-priced medications distort the calculation
Solution Approach 1:
The patent applies different inclusion criteria to different medication groups based on their characteristics. Established medications with stable pricing are included in representative price calculations to ensure accuracy, while new or high-priced medications are initially excluded to prevent distortion. This local quality approach allows precise measurements where data is reliable while maintaining system integrity.
Data Source
AI summary
A method is disclosed by which pharmacies and physicians are encouraged to select appropriate and effective medications but dissuaded from selecting higher priced medications where more economical versions are available as alternatives, but where physicians and patients can also select such higher priced medications if they so choose and are prepared to pay that higher price. Under this system a single representative price (capitation rate) is calculated by a prescription payment plan manager for a group of related medications, usually including both branded and generic, and that price is paid to a pharmacy for all prescriptions of that group of medications fulfilled under the plan. The representative prices for different groups, including their minimum levels, are periodically reviewed and updated as appropriate.